1. Home
  2. OZ vs ACHV Comparison

OZ vs ACHV Comparison

Compare OZ & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belpointe PREP LLC Units

OZ

Belpointe PREP LLC Units

N/A

Current Price

$52.34

Market Cap

245.7M

Sector

N/A

ML Signal

N/A

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

N/A

Current Price

$4.18

Market Cap

233.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OZ
ACHV
Founded
2020
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
245.7M
233.2M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
OZ
ACHV
Price
$52.34
$4.18
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$15.50
AVG Volume (30 Days)
11.5K
321.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
17.33
EPS
N/A
N/A
Revenue
$2,675,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.68
N/A
52 Week Low
$48.50
$1.84
52 Week High
$75.73
$6.03

Technical Indicators

Market Signals
Indicator
OZ
ACHV
Relative Strength Index (RSI) 56.37 43.39
Support Level $52.02 $3.93
Resistance Level $64.85 $4.30
Average True Range (ATR) 1.05 0.23
MACD 0.48 -0.00
Stochastic Oscillator 85.13 16.31

Price Performance

Historical Comparison
OZ
ACHV

About OZ Belpointe PREP LLC Units

Belpointe PREP LLC is a qualified opportunity fund. The company's investments consist of properties located in qualified opportunity zones for the development or redevelopment of multifamily, student housing, senior living, healthcare, industrial, self-storage, hospitality, office, mixed-use, data centers, and solar projects located throughout the United States and its territories. Company currently has two reporting segments, commercial: includes properties such as office, retail centers, and warehouses; and mixed-use: includes properties that blend both residential and retail components within a single real estate asset.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

Share on Social Networks: